Andrea Pesch
University of Michigan
H-index: 7
North America-United States
Top articles of Andrea Pesch
Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR Inhibition
International Journal of Radiation Oncology, Biology, Physics
2023/10/1
Multiomics analysis to uncover the mechanism of radiosensitization of AR-positive triple negative breast cancers with AR inhibition
Cancer Research
2022/6/15
Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER+ breast cancers
International Journal of Radiation Oncology, Biology, Physics
2021/11/1
Expression of DNA damage response proteins modifies the efficacy of CDK4/6 inhibitor-mediated radiosensitization in breast cancer models
Cancer Research
2022/6/15
Results: A total of 143 participants with PRO and genetic data were included in this analysis, most of whom were treated with anastrozole (78%) or letrozole (20%). On primary …
Pharmacogenomics of Adverse Drug Reactions (ADRs)
2022/4/1
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
NPJ Breast Cancer
2022/3/10
RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
JCI insight
2022/2/2
Appendix A: PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation6
Defining the Role of Nuclear Hormone Receptors in Response to Radiation Therapy: Targeted Therapies for Radiosensitization in Androgen Receptor-Positive and Estrogen Receptor-Positive Breast Cancers
2022
Targeting DNA Damage, Apoptosis, and the Cell Cycle for the Radiosensitization of Aggressive Forms of Breast Cancer
2022
Andrea Pesch
H-Index: 3
Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
NPJ Breast Cancer
2022
Endocrine therapy treatment radiosensitizes estrogen receptor-positive breast cancers
Cancer Research
2022
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
British Journal of Cancer
2022/9/1
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
Cancer research communications
2022/7/20
MDM2 inhibition as a non-hormone dependent radiosensitizing strategy in p53 wild-type breast cancer models
Cancer Research
2022/6/15
CDK4/6 Inhibition and Radiation as a Treatment Strategy to Improve Local Disease Control in Breast Cancers With Poor Prognoses
International Journal of Radiation Oncology, Biology, Physics
2021/11/1
CDK4/6 inhibition radiosensitizes RB1 wild type triple negative breast cancers through impaired homologous recombination
Cancer Research
2021/7/1
Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER+ breast cancer models
Cancer Research
2021/7/1
Radiosensitization of PIK3CA wild type triple negative breast cancers with Bcl-family inhibition
Cancer Research
2021/7/1
The role of MDM2 inhibition in the radiosensitization of ER+ breast cancers
Cancer Research
2021/7/1
Further evidence that OPG rs2073618 is associated with increased risk of musculoskeletal symptoms in patients receiving aromatase inhibitors for early breast cancer
Frontiers in Genetics
2021/6/15
